1 Introduction to Research & Analysis Reports
    1.1 Clinical Oncology Next Generation Sequencing Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Clinical Oncology Next Generation Sequencing Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Clinical Oncology Next Generation Sequencing Overall Market Size
    2.1 Global Clinical Oncology Next Generation Sequencing Market Size: 2021 VS 2027
    2.2 Global Clinical Oncology Next Generation Sequencing Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Clinical Oncology Next Generation Sequencing Players in Global Market
    3.2 Top Global Clinical Oncology Next Generation Sequencing Companies Ranked by Revenue
    3.3 Global Clinical Oncology Next Generation Sequencing Revenue by Companies
    3.4 Top 3 and Top 5 Clinical Oncology Next Generation Sequencing Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Clinical Oncology Next Generation Sequencing Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Clinical Oncology Next Generation Sequencing Players in Global Market
        3.6.1 List of Global Tier 1 Clinical Oncology Next Generation Sequencing Companies
        3.6.2 List of Global Tier 2 and Tier 3 Clinical Oncology Next Generation Sequencing Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Clinical Oncology Next Generation Sequencing Market Size Markets, 2021 & 2027
        4.1.2 Whole Genome Sequencing
        4.1.3 Whole Exome Sequencing
        4.1.4 Targeted Sequencing & Resequencing Centrifuges
    4.2 By Type - Global Clinical Oncology Next Generation Sequencing Revenue & Forecasts
        4.2.1 By Type - Global Clinical Oncology Next Generation Sequencing Revenue, 2016-2021
        4.2.2 By Type - Global Clinical Oncology Next Generation Sequencing Revenue, 2022-2027
        4.2.3 By Type - Global Clinical Oncology Next Generation Sequencing Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Clinical Oncology Next Generation Sequencing Market Size, 2021 & 2027
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Laboratories
    5.2 By Application - Global Clinical Oncology Next Generation Sequencing Revenue & Forecasts
        5.2.1 By Application - Global Clinical Oncology Next Generation Sequencing Revenue, 2016-2021
        5.2.2 By Application - Global Clinical Oncology Next Generation Sequencing Revenue, 2022-2027
        5.2.3 By Application - Global Clinical Oncology Next Generation Sequencing Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Clinical Oncology Next Generation Sequencing Market Size, 2021 & 2027
    6.2 By Region - Global Clinical Oncology Next Generation Sequencing Revenue & Forecasts
        6.2.1 By Region - Global Clinical Oncology Next Generation Sequencing Revenue, 2016-2021
        6.2.2 By Region - Global Clinical Oncology Next Generation Sequencing Revenue, 2022-2027
        6.2.3 By Region - Global Clinical Oncology Next Generation Sequencing Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Clinical Oncology Next Generation Sequencing Revenue, 2016-2027
        6.3.2 US Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
        6.3.3 Canada Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
        6.3.4 Mexico Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Clinical Oncology Next Generation Sequencing Revenue, 2016-2027
        6.4.2 Germany Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
        6.4.3 France Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
        6.4.4 U.K. Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
        6.4.5 Italy Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
        6.4.6 Russia Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
        6.4.7 Nordic Countries Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
        6.4.8 Benelux Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Clinical Oncology Next Generation Sequencing Revenue, 2016-2027
        6.5.2 China Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
        6.5.3 Japan Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
        6.5.4 South Korea Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
        6.5.5 Southeast Asia Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
        6.5.6 India Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Clinical Oncology Next Generation Sequencing Revenue, 2016-2027
        6.6.2 Brazil Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
        6.6.3 Argentina Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Clinical Oncology Next Generation Sequencing Revenue, 2016-2027
        6.7.2 Turkey Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
        6.7.3 Israel Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
        6.7.4 Saudi Arabia Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
        6.7.5 UAE Clinical Oncology Next Generation Sequencing Market Size, 2016-2027
7 Players Profiles
    7.1 Illumina, Inc.
        7.1.1 Illumina, Inc. Corporate Summary
        7.1.2 Illumina, Inc. Business Overview
        7.1.3 Illumina, Inc. Clinical Oncology Next Generation Sequencing Major Product Offerings
        7.1.4 Illumina, Inc. Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
        7.1.5 Illumina, Inc. Key News
    7.2 Thermo Fisher Scientific
        7.2.1 Thermo Fisher Scientific Corporate Summary
        7.2.2 Thermo Fisher Scientific Business Overview
        7.2.3 Thermo Fisher Scientific Clinical Oncology Next Generation Sequencing Major Product Offerings
        7.2.4 Thermo Fisher Scientific Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
        7.2.5 Thermo Fisher Scientific Key News
    7.3 F. Hoffmann-La Roche Ltd.
        7.3.1 F. Hoffmann-La Roche Ltd. Corporate Summary
        7.3.2 F. Hoffmann-La Roche Ltd. Business Overview
        7.3.3 F. Hoffmann-La Roche Ltd. Clinical Oncology Next Generation Sequencing Major Product Offerings
        7.3.4 F. Hoffmann-La Roche Ltd. Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
        7.3.5 F. Hoffmann-La Roche Ltd. Key News
    7.4 Agilent Technologies
        7.4.1 Agilent Technologies Corporate Summary
        7.4.2 Agilent Technologies Business Overview
        7.4.3 Agilent Technologies Clinical Oncology Next Generation Sequencing Major Product Offerings
        7.4.4 Agilent Technologies Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
        7.4.5 Agilent Technologies Key News
    7.5 Myriad Genetics
        7.5.1 Myriad Genetics Corporate Summary
        7.5.2 Myriad Genetics Business Overview
        7.5.3 Myriad Genetics Clinical Oncology Next Generation Sequencing Major Product Offerings
        7.5.4 Myriad Genetics Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
        7.5.5 Myriad Genetics Key News
    7.6 Beijing Genomics Institute (BGI)
        7.6.1 Beijing Genomics Institute (BGI) Corporate Summary
        7.6.2 Beijing Genomics Institute (BGI) Business Overview
        7.6.3 Beijing Genomics Institute (BGI) Clinical Oncology Next Generation Sequencing Major Product Offerings
        7.6.4 Beijing Genomics Institute (BGI) Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
        7.6.5 Beijing Genomics Institute (BGI) Key News
    7.7 Perkin Elmer
        7.7.1 Perkin Elmer Corporate Summary
        7.7.2 Perkin Elmer Business Overview
        7.7.3 Perkin Elmer Clinical Oncology Next Generation Sequencing Major Product Offerings
        7.4.4 Perkin Elmer Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
        7.7.5 Perkin Elmer Key News
    7.8 Foundation Medicine
        7.8.1 Foundation Medicine Corporate Summary
        7.8.2 Foundation Medicine Business Overview
        7.8.3 Foundation Medicine Clinical Oncology Next Generation Sequencing Major Product Offerings
        7.8.4 Foundation Medicine Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
        7.8.5 Foundation Medicine Key News
    7.9 Pacific Bioscience
        7.9.1 Pacific Bioscience Corporate Summary
        7.9.2 Pacific Bioscience Business Overview
        7.9.3 Pacific Bioscience Clinical Oncology Next Generation Sequencing Major Product Offerings
        7.9.4 Pacific Bioscience Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
        7.9.5 Pacific Bioscience Key News
    7.10 Oxford Nanopore Technologies Ltd.
        7.10.1 Oxford Nanopore Technologies Ltd. Corporate Summary
        7.10.2 Oxford Nanopore Technologies Ltd. Business Overview
        7.10.3 Oxford Nanopore Technologies Ltd. Clinical Oncology Next Generation Sequencing Major Product Offerings
        7.10.4 Oxford Nanopore Technologies Ltd. Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
        7.10.5 Oxford Nanopore Technologies Ltd. Key News
    7.11 Paradigm Diagnostics
        7.11.1 Paradigm Diagnostics Corporate Summary
        7.11.2 Paradigm Diagnostics Business Overview
        7.11.3 Paradigm Diagnostics Clinical Oncology Next Generation Sequencing Major Product Offerings
        7.11.4 Paradigm Diagnostics Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
        7.11.5 Paradigm Diagnostics Key News
    7.12 Caris Life Sciences
        7.12.1 Caris Life Sciences Corporate Summary
        7.12.2 Caris Life Sciences Business Overview
        7.12.3 Caris Life Sciences Clinical Oncology Next Generation Sequencing Major Product Offerings
        7.12.4 Caris Life Sciences Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
        7.12.5 Caris Life Sciences Key News
    7.13 Partek, Inc.
        7.13.1 Partek, Inc. Corporate Summary
        7.13.2 Partek, Inc. Business Overview
        7.13.3 Partek, Inc. Clinical Oncology Next Generation Sequencing Major Product Offerings
        7.13.4 Partek, Inc. Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
        7.13.5 Partek, Inc. Key News
    7.14 Eurofins Scientific S.E.
        7.14.1 Eurofins Scientific S.E. Corporate Summary
        7.14.2 Eurofins Scientific S.E. Business Overview
        7.14.3 Eurofins Scientific S.E. Clinical Oncology Next Generation Sequencing Major Product Offerings
        7.14.4 Eurofins Scientific S.E. Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
        7.14.5 Eurofins Scientific S.E. Key News
    7.15 Qiagen N.V.
        7.15.1 Qiagen N.V. Corporate Summary
        7.15.2 Qiagen N.V. Business Overview
        7.15.3 Qiagen N.V. Clinical Oncology Next Generation Sequencing Major Product Offerings
        7.15.4 Qiagen N.V. Clinical Oncology Next Generation Sequencing Revenue in Global (2016-2021)
        7.15.5 Qiagen N.V. Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer